glycyrrhizic acid has been researched along with lithocholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Li, H; Liang, QD; Ma, ZC; Tan, HL; Wang, YG; Xiao, CR; Zhang, BL; Zhou, JM | 1 |
| Gao, YJ; Han, JC; Yu, J | 1 |
2 other study(ies) available for glycyrrhizic acid and lithocholic acid
| Article | Year |
|---|---|
Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Cytochrome P-450 CYP3A; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Induction; Gene Expression Regulation; Glycyrrhizic Acid; Hep G2 Cells; Humans; Lithocholic Acid; Liver; Male; Mice; Pregnane X Receptor; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Time Factors; Transcription, Genetic | 2012 |
Lipidomics investigation of reversal effect of glycyrrhizin (GL) towards lithocholic acid (LCA)-induced alteration of phospholipid profiles.
Topics: Alanine Transaminase; Animals; Glycyrrhizic Acid; Injections, Intraperitoneal; Lipid Metabolism; Lipids; Lithocholic Acid; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Phospholipids | 2014 |